- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02347969
Evaluation of the Effect of the Dietary Supplement X34 on Skin Radiance of Healthy Volunteers With Dull Complexion
September 20, 2016 updated by: Nutratech Conseils
The main objective of this trial is to evaluate the effect of the daily dose of X34 dietary supplement on skin radiance (clinical assessment) for 8 weeks.
Study Overview
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female volunteers:
- Age: 40-70 years
- Who have a dull complexion evaluated by clinical scoring
- Phototype II to IV (annex 5)
- Non-smoking or smoking less than 5 cigarettes per day
- Did not change her eating habits, within one month before the start of the study and agreeing not change during the study
- With no history of facial skin care (peeling, mask…) 15 days before the beginning of the study and agreeing not to perform during the study
- Volunteers accepting not changing their local treatment on face
- Who agree to avoid UV exposure (sun or tanning booth) during the study
- Who have a fixed address and are entitled to Social Security or a similar National Insurance scheme
- Who sign a written informed consent
Exclusion Criteria:
- Pregnant, nursing, or intending to become pregnant in the course of the study
- With a history of allergy or hypersensitivity to the products or one of their components
- Having use oral nutritional supplements and/or vitamin supplementation less than one month before and/or refusing not consuming nutritional supplement during the study
- Having used cosmetics and/or topical preparations containing ingredients claiming efficacy on skin radiance less than 15 days before and/or during the study
- With a dermatosis, systemic disease or treatment susceptible to interfere with the evolution of the parameters of the study or with taking the nutritional supplement
- Participation in another clinical trial evaluating skin radiance during the last month before the study
- Participation in another clinical trial or volunteers being in the exclusion phase of such a trial, thus being unable to participate in any other one
- Who have forfeited their freedom by judiciary decision or are deemed legally incompetent
- Having perceived more than 4500 € as indemnification fees for participation in clinical trials during the preceding 12 months (including participation in this clinical trial)
- Unable to comply with the protocol constraints
- Who cannot be contacted by phone rapidly
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: X34
Arm supplemented with X34
|
Dietary supplement named X34
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Skin radiance: clinical scoring
Time Frame: At 0 week and 8 weeks
|
At 0 week and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subject self-assessments
Time Frame: At 0 week and 8 weeks
|
Subjects will evaluate the radiance of their complexion by self-assessment.
|
At 0 week and 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
January 16, 2015
First Submitted That Met QC Criteria
January 22, 2015
First Posted (Estimate)
January 28, 2015
Study Record Updates
Last Update Posted (Estimate)
September 21, 2016
Last Update Submitted That Met QC Criteria
September 20, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- DE-87
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States